Search research articles
Contact Us
Filters
Showing results (31-40 of 339) with videos related to
Page
of 34
Sort By:
Reviews in Clinical and Experimental Hematology
|
July 20, 2005
Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes
Carlo Aul, Aristoteles Giagounidis, Michael Heinsch, et al.
Leukemia Research
|
May 12, 2009
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy
Sebastian Balleisen, Andrea Kuendgen, Barbara Hildebrandt, et al.
Therapeutics and Clinical Risk Management
|
May 14, 2008
Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes
Aristoteles A N Giagounidis, Ulrich Germing, Sabine Haase, et al.
American Journal of Hematology
|
June 8, 2012
Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database
Ofir Shukron, Vladimir Vainstein, Andrea Kündgen, et al.
International Journal of Hematology
|
November 17, 2017
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation
Thomas Schroeder, Christina Rautenberg, Rainer Haas, et al.
Leukemia Research
|
June 4, 2016
Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?)
John M Bennett, Heinz Tuechler, Carlo Aul, et al.
Leukemia Research
|
December 5, 2003
Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics
Detlef Trost, Barbara Hildebrandt, Nicola Müller, et al.
Leukemia Research
|
July 22, 2008
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia
Frank Neumann, Norbert Gattermann, Hans-Ulrich Barthelmes, et al.
Annals of Hematology
|
January 11, 2007
Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib
Matthias Drechsler, Barbara Hildebrandt, Andrea Kündgen, et al.
Blood Advances
|
October 15, 2021
Impaired formation of neutrophil extracellular traps in patients with MDS
Carolin Brings, Julia Fröbel, Patrick Cadeddu, et al.
Page
of 34
Search research articles
Search
Showing results (31-40 of 339) with videos related to
Sort By:
Page
of 34
Reviews in Clinical and Experimental Hematology
|
July 20, 2005
Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes
Carlo Aul, Aristoteles Giagounidis, Michael Heinsch, et al.
Leukemia Research
|
May 12, 2009
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy
Sebastian Balleisen, Andrea Kuendgen, Barbara Hildebrandt, et al.
Therapeutics and Clinical Risk Management
|
May 14, 2008
Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes
Aristoteles A N Giagounidis, Ulrich Germing, Sabine Haase, et al.
American Journal of Hematology
|
June 8, 2012
Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database
Ofir Shukron, Vladimir Vainstein, Andrea Kündgen, et al.
International Journal of Hematology
|
November 17, 2017
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation
Thomas Schroeder, Christina Rautenberg, Rainer Haas, et al.
Leukemia Research
|
June 4, 2016
Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?)
John M Bennett, Heinz Tuechler, Carlo Aul, et al.
Leukemia Research
|
December 5, 2003
Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics
Detlef Trost, Barbara Hildebrandt, Nicola Müller, et al.
Leukemia Research
|
July 22, 2008
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia
Frank Neumann, Norbert Gattermann, Hans-Ulrich Barthelmes, et al.
Annals of Hematology
|
January 11, 2007
Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib
Matthias Drechsler, Barbara Hildebrandt, Andrea Kündgen, et al.
Blood Advances
|
October 15, 2021
Impaired formation of neutrophil extracellular traps in patients with MDS
Carolin Brings, Julia Fröbel, Patrick Cadeddu, et al.
Page
of 34